Recent studies have demonstrated that PDHA1 phosphorylation could promote tumor migration ability and therapeutic resistance by suppressing its PDH activity (Zimmer et al., 2016; Jin et al., 2021). This evidence concerns the gene PDHA1 and neoplasm.